Christina Avanti

Dr. Christina Avanti

Pharmaceutics, University of Surabaya, Surabaya, Jawa Timur, Indonesia
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 March 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
PNPrimawan Putra Nugrahadi
Primawan Putra Nugrahadi
Wouter L.J. HinrichsWouter L.J. Hinrichs
Wouter L.J. Hinrichs
HFHenderik Frijlink
Henderik Frijlink
CSChristian Schoneich
Christian Schoneich
CAChristina Avanti
Christina Avanti
Over the past few decades, there has been a tremendous increase in the utilization of therapeutic peptides. Therapeutic peptides are usually administered via the parenteral route, requiring an aqueous formulation. Unfortunately, peptides are often unstable in aqueous solutions, affecting stability and bioactivity. Although a stable and dry formulation for reconstitution might be designed, from a pharmaco-economic and practical convenience point of view, a peptide formulation in an aqueous liquid form is preferred. Designing formulation strategies that optimize peptide stability may improve bioavailability and increase therapeutic efficacy. This literature review provides an overview of various degradation pathways and formulation strategies to stabilize therapeutic peptides in aqueous solutions. First, we introduce the major peptide stability issues in liquid formulations and the degradation mechanisms. Then, we present a variety of known strategies to inhibit or slow down peptide degradation. Overall, the most practical approaches to peptide stabilization are pH optimization and selecting the appropriate type of buffer. Other practical strategies to reduce peptide degradation rates in solution are the application of co-solvency, air exclusion, viscosity enhancement, PEGylation, and using polyol excipients.

3 April 2020 in Biodiversitas Journal of Biological Diversity
Verified
Journal Article
Open access
PDF file
JSJohan Sukweenadhi
Johan Sukweenadhi
OYOeke Yunita
Oeke Yunita
FSFinna Setiawan
Finna Setiawan
KKKartini Kartini
Kartini Kartini
MSMaya Theresa Siagian
Maya Theresa Siagian
CAChristina Avanti
Christina Avanti
Sukweenadi J, Yunita O, Setiawan F, Kartini, Siagian MT, Danduru AP, Avanti C. 2020. Antioxidant Activity Screening of Seven Indonesian Herbal Extract. Biodiversitas 21: 2062-2067. Kumis kucing (Orthosiphon stamineus), pegagan (Centella asiatica), seledri (Apium graveolens), kunyit (Curcuma domestica), temulawak (Curcuma xanthorrhiza), tempuyung (Sonchus arvensis) and meniran (Phyllanthus niruri) are herbs that commonly used in the Indonesia folk medicine. The constituents that responsible for several important biological activities are phenolic and flavonoid compounds which also possess antioxidant activity. Antioxidant activity of those seven Indonesian herbal extracts was evaluated using DPPH, ABTS and FRAP methods. The extraction was done with the reflux method by using 80% ethanol as a solvent. The total phenol and total flavonoids from each herbal extract were measured using Folin–Ciocalteu reagent and spectrophotometry. Antioxidant activity results by DPPH method on O. stamineus, C. asiatica, A. graveolens, C. domestica, C. xanthorrhiza, S. arvensis, and P. niruri showed IC50 value at 132; ND; 2221; 361; 538; 1118; and 102 ppm, respectively. Results from ABTS method, showed IC50 value at 22; 1199; 169; 100; 82; 143; and 20 ppm respectively. While results from the FRAP method showed that the ethanolic extract of P. niruri at a concentration of 20 ppm possesses the strongest antioxidant activity (17.41 ppm AEAC/ppm extract). The content of total phenolic compounds are 22.50; 0.67; 2.16; 11.40; 7.80; 7.22; and 2.62% GAE, while the total flavonoid compounds were 19.88; 6.67; 4.06; 71.02; 34.62; 3.78; and 8.34% QE, respectively. It can be concluded that ethanolic extract of P. niruri and O. stamineus obtain the highest antioxidant activity based on DPPH, ABTS and FRAP method.

23 January 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
CAChristina Avanti
Christina Avanti
VSVinay Saluja
Vinay Saluja
ESErwin L. P. van Streun
Erwin L. P. van Streun
HFHenderik Frijlink
Henderik Frijlink
Wouter L.J. HinrichsWouter L.J. Hinrichs
Wouter L.J. Hinrichs
The purpose of this study was to investigate the stability of lysozyme in aqueous solutions in the presence of various extremolytes (betaine, hydroxyectoine, trehalose, ectoine, and firoin) under different stress conditions. The stability of lysozyme was determined by Nile red Fluorescence Spectroscopy and a bioactivity assay. During heat shock (10 min at 70°C), betaine, trehalose, ectoin and firoin protected lysozyme against inactivation while hydroxyectoine, did not have a significant effect. During accelerated thermal conditions (4 weeks at 55°C), firoin also acted as a stabilizer. In contrast, betaine, hydroxyectoine, trehalose and ectoine destabilized lysozyme under this condition. These findings surprisingly indicate that some extremolytes can stabilize a protein under certain stress conditions but destabilize the same protein under other stress conditions. Therefore it is suggested that for the screening extremolytes to be used for protein stabilization, an appropriate storage conditions should also be taken into account.

17 August 2020 in Processes
Verified
Journal Article
Open access
PDF file
KKKartini Kartini
Kartini Kartini
AAAmarisa Alviani
Amarisa Alviani
DADia Anjarwati
Dia Anjarwati
AFAdinda Finna Fanany
Adinda Finna Fanany
Johan SukweenadhiJohan Sukweenadhi
Johan Sukweenadhi
CAChristina Avanti
Christina Avanti
Silver nanoparticles (AgNPs) are an interesting metal nanoparticle that can be incorporated into pharmaceutical products, including for diabetic foot ulcers as an antimicrobial agent. Green synthesis of AgNPs using plant extracts has been drawing much attention as it is simple, eco-friendly, stable, and cost-effective. This present study was performed to evaluate the potential of three Indonesian medicinal plant extracts, namely Phyllanthus niruri (PN), Orthosiphon stamineus (OS), and Curcuma longa (CL), as reducing and capping agents in the green synthesis of AgNPs, and to optimize their concentrations. Based on the yields and characteristics of the formed nanoparticles, which were analyzed using a UV-Vis spectrophotometer, particle size analyzer, scanning electron microscope, and X-ray diffractometer, Phyllanthus niruri extract at a concentration of 0.5% was concluded as the best extract in the green synthesis of AgNPs. It is thereby a prospective reducing and capping agent for further scale-up studies.

12 March 2024 in Pharmacia
Verified
Journal Article
Open access
PDF file
EFEndang Wahyu Fitriani
Endang Wahyu Fitriani
CAChristina Avanti
Christina Avanti
YRYeva Rosana
Yeva Rosana
SSSilvia Surini
Silvia Surini
Nanostructured lipid carriers (NLCs) are versatile tools used for several purposes, including drug release modification, adhesion to the skin, film-forming ability followed by hydration of the superficial layers of the skin, as well as high penetration with permeation into and across deeper skin layers. During the formulation of active ingredients sourced from nature into dosage forms, NLCs play a crucial role in overcoming challenges associated with the process. These challenges include poor solubility and skin permeability, sensitivity to light, heat, and oxygen, leading to degraded quality, reduced potency, and probable risks of skin irritation or allergic reactions. Therefore, this review aimed to provide a comprehensive overview of NLCs as effective delivery system through the skin for natural active ingredients. The extensive discussion covers the advantages and disadvantages of a dermal delivery system for these ingredients, focusing on various types, lipids, and surfactants used in the formulation, preparation, and characterization process. Additionally, the recent developments in NLCs technology are explored. The result showed that NLCs would advance into a more efficient, precise, and safe system to transport natural active ingredients dermally.

19 October 2021 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
KRKarina Citra Rani
Karina Citra Rani
NPNani Parfati
Nani Parfati
NANi Luh Dewi Aryani
Ni Luh Dewi Aryani
AWAgnes Nuniek Winantari
Agnes Nuniek Winantari
EFEndang Wahyu Fitriani
Endang Wahyu Fitriani
CAChristina Avanti
Christina Avanti
The development of oral dissolving film (ODF) of atenolol is an attempt to enhance convenience and compliance for geriatric patients suffering from hypertension. Film former is the most essential component in ODF that determines the physical characteristic and drug release. In this study, three different types of film former including HPMC E5 4% (w/v), 5% (w/v), CMC-Na 3% (w/v), 4% (w/v), and Na-alginate 2.5% (w/v), 3% (w/v) were optimized in Formula 1 (F1) to Formula 6 (F6), respectively. A solvent casting method was employed to develop ODF of atenolol. The films formed by HPMC E5 produced a smooth and flexible surface, whereas CMC-Na and Na-alginate produced gritty textured films. Satisfactory results were obtained from several physical parameters such as film thickness, folding endurance, swelling index, and disintegration time. The homogeneity, drug content, and dissolution properties of ODF with HPMC exhibited better characteristics than the other formulas. Formula 1 exhibited the highest drug release compared to the other ODFs. The molecular docking results showed that there was a hydrogen bonding between atenolol and film formers which was also supported by the FTIR spectrum. The findings of this study suggest that HPMC E5 is the most favorable film former for ODF of atenolol.